- Generic name
- Chlorthalidone
- Strength
- 25 mg
- Dosage form
- Tablet
- Manufactured by
- Advanced Chemical Industries PLC
Clortha 25 Tablet
About Clortha 25 Tablet
Clortha 25 is a 25 mg tablet made by Advanced Chemical Industries PLC. It contains chlorthalidone, a thiazide-type diuretic and antihypertensive medicine that doctors prescribe for high blood pressure and for some types of swelling.
What is Clortha 25 Tablet?
Clortha 25 Tablet is a prescription medicine from Advanced Chemical Industries PLC. Its active ingredient is chlorthalidone 25 mg, which belongs to the thiazide diuretics and related drugs group. It works on the kidneys to increase water loss and is used in the management of hypertension, and as adjunctive therapy for edema linked to heart failure, liver cirrhosis and corticosteroid or estrogen therapy. The doctor sets the dose and course for each patient. Tell your doctor about kidney or liver problems, pregnancy, breastfeeding and other medicines before starting it.
Uses of Clortha 25
Clortha 25 is used in the management of hypertension, either alone or with other blood pressure medicines. It is also used as adjunctive therapy for edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid or estrogen therapy. Your doctor will decide whether it suits your condition and will set the dose and course for you.
How to use Clortha 25
Take Clortha 25 exactly as your doctor instructs; the dose and course are decided by the doctor. A single daily or alternate-day dose in the morning with food is the usual schedule described for this medicine. Swallow the tablet with water. Do not change the dose or stop on your own. Ask your doctor or pharmacist if you are unsure how to take it or miss a dose.
Side effects of Clortha 25
Common effects are mainly seen at higher doses and include low potassium, raised uric acid and a rise in blood lipids. Less often there may be low sodium, low magnesium, high blood sugar, skin rash or dizziness, and rare effects include jaundice, photosensitization and heart rhythm problems. Call your doctor if you feel very weak, dizzy or unwell, or notice a rash, yellowing of the skin or an irregular heartbeat.
Safety and precautions
Clortha 25 is not to be used in pregnancy to treat hypertension, and its use in pregnancy for other conditions should be avoided unless the doctor decides the benefits outweigh the risks. It passes into breast milk and can suppress lactation, so it should not be prescribed for breastfeeding mothers. Tell your doctor before use if you have kidney or liver disease, gout, low potassium or sodium, high calcium, or a sulfonamide allergy, and mention all other medicines you take.
Frequently asked questions
What is Clortha 25 used for and what kind of medicine is it?
Clortha 25 is a thiazide-type diuretic and antihypertensive tablet containing chlorthalidone 25 mg. It is used in the management of hypertension and as adjunctive therapy for edema linked to heart failure, liver cirrhosis and corticosteroid or estrogen therapy. The doctor decides if it suits you.
Is Clortha 25 safe in pregnancy or breastfeeding?
It should not be used to treat hypertension in pregnancy, and other uses in pregnancy should be avoided unless the doctor judges the benefits outweigh the risks. It passes into breast milk and can suppress lactation, so it should not be prescribed for breastfeeding mothers. Ask your doctor.
What side effects should I watch for and when should I call the doctor?
Watch for weakness, dizziness, skin rash, yellowing of the skin or an irregular heartbeat, along with changes in blood electrolytes and uric acid. Call your doctor promptly if you notice any of these, or if you feel unwell after starting Clortha 25.
Who should ask the doctor before taking Clortha 25?
Ask your doctor first if you have kidney or liver disease, gout, low potassium or sodium, high calcium, or an allergy to sulfonamides, and if you are pregnant or breastfeeding. Mention every other medicine you take, including blood pressure medicines, so the doctor can check for interactions.
Indications
Pharmacology
Chlorthalidone inhibits the reabsorption of sodium and chloride in the distal renal tubule thus promoting water loss. The higher urine volume increases potassium loss. Little information is available on the absorption of the drug. Its long elimination half-life and clinical experience place it as a long-acting thiazide derivative. The longer-acting agents appear to cause increased potassium loss.
Although a mild diuretic, its combination with loop diuretics is particularly potent because the latter presents much more sodium chloride to the distal tubule.
The blood pressure lowering effects are initially due to volume reduction but the persisting effect includes other undetermined mechanisms that reduce peripheral resistance. A high salt intake reverses its antihypertensive effect.
The major portion of an absorbed dose of Chlorthalidone is excreted by the kidneys with an elimination half life averaging 50 hours. Metabolism and hepatic excretion into the bile constitute a minor way of elimination. Within 120 hours, about 70% of the dose is excreted in the urine and in the feces, mainly in an unchanged form.
Dosage & Administration
Hypertension: Usual adult dose is 25 to 50 mg daily. The clinically useful dosage range is 12.5 to 50 mg daily. Doses greater than 50 mg per day increase metabolic complications and are rarely of therapeutic benefit. For a given dose, the full effect is reached after 3 to 4 weeks. If the decrease in blood pressure obtained using doses of 25 or 50 mg/day proves inadequate, combined treatment with other antihypertensive drugs (such as beta-blockers and ACE inhibitors) is recommended. When adding an ACE inhibitor, Chlorthalidone is to be reduced or discontinued.
Edema of Specific Origin: The lowest effective dose is to be identified by titration. Maintenance doses should not exceed 50 mg/day and should be administered over limited periods only. The dosage should be individually adapted to the clinical picture and patient response. For long-term therapy, the lowest possible dosage sufficient to maintain an optimal effect should be employed; this applies particularly to elderly patients.
The therapeutic effect of Chlorthalidone occurs even without salt restriction and is well sustained during continued use.
The elderly: This is a suitable drug for treating hypertension in the elderly, in particular systolic hypertension. Dose of 50 mg daily, or less, should be used to avoid hypovolemia and hypokalemia.
Interaction
Drug Interactions-
Antihypertensive Agents: Diuretics potentiate the action of curare derivatives and antihypertensive agents (e.g. guanethidine, methyldopa, beta-blockers, vasodilators, calcium antagonists, ACE inhibitors).
Digitalis: Thiazide-induced hypokalemia or hypomagnesemia may increase the likelihood of digitalis-induced cardiac arrhythmias (see also Precautions).
Corticosteroids: The hypokalemic effects of diuretics may be increased by corticosteroids, ACTH and amphotericin. Insulin and Oral Antidiabetic Agents: It may be necessary to adjust the dosage of insulin or oral antidiabetic agents in response to changes in glucose tolerance that Chlorthalidone may produce.
NSAIDs: Concomitant administration of certain NSAIDs (e.g. indomethacin) may weaken the diuretic and antihypertensive activity of thiazides, and there have been isolated reports of a deterioration of renal function in predisposed patients.
Curare Derivatives and Ganglionic Blocking Agents: Thiazides may increase responsiveness to curare derivatives and ganglionic blocking agents.
Allopurinol: Co-administration of thiazide diuretics may increase the incidence of hypersensitivity reactions to allopurinol.
Amantadine: Co-administration of thiazide diuretics may increase the risk of adverse effects from amantadine.
Antineoplastic Agents (e.g. cyclophosphamide, methotrexate): Concomitant use of thiazide diuretics may reduce renal excretion of cytotoxic agents and enhance the myelo suppressive effects. Anticholinergics (e.g. atropine, biperiden): The bioavailability of thiazide-type diuretics may be increased by anticholinergic agents, apparently due to a decrease in gastrointestinal motility and rate of gastric emptying.
Cholestyramine: Absorption of thiazide diuretics is decreased by cholestyramine, therefore a decrease in pharmacological effect may be expected.
Vitamin D: Concomitant use of thiazide diuretics may decrease urinary excretion of calcium, and co-administration of Vitamin D may potentiate the increase in serum calcium.
Cyclosporin: Concomitant treatment with diuretics may increase the risk of hyperuricemia and gout-type complications.
Calcium Salts: Concomitant use of thiazide-type diuretics may cause hypercalcemia by increasing tubular calcium reabsorption.
Diazoxide: Thiazide diuretics may enhance the hyperglycemic effect of diazoxide.
Contraindications
Should be used with caution in patients with renal disease or with impaired hepatic function. Because of the possibility of progression of renal damage, periodic determination of the BUN and serum creatinine are indicated. Should there be an elevation of either parameter, treatment should be discontinued. Like thiazides, Chlorthalidone may lose its diuretic efficacy when glomerular filtration rate drops below 30 mL/min, a point at which treatment with loop diuretics may be more appropriate.
Electrolytes: As with thiazide diuretics, kaluresis induced by Chlorthalidone is dose dependent, and there is inter-individual variability in magnitude. With 25 mg/day, serum potassium concentration decreases average 0.5 mmol/L. If chronic treatment is contemplated, serum potassium concentrations should be determined initially, and then 3 to 4 weeks later. If thereafter, potassium balance is not disturbed further, concentrations should be assessed every 4 to 6 months. Conditions that may alter potassium balance include: vomiting, diarrhea, malnutrition, change in renal function (e.g. nephrosis), liver cirrhosis, hyperaldosteronism, or concomitant use of corticosteroids or ACTH. Titrated co-administration of an oral potassium salt (e.g. KCI) may be considered in patients: receiving digitalis; exhibiting signs of coronary heart disease, unless they are also receiving an ACE inhibitor; on high doses of a beta-adrenergic agonist; whose plasma potassium concentrations are less than 3.0 mmol/L.
Side Effects
Isolated cases: hypochloremic alkalosis.
Dermatology: Occasional: urticaria and other forms of skin rash. Rare: photosensitization.
Liver: Rare: Intrahepatic cholestasis or jaundice.
Cardiovascular: Occasional: postural hypotension, which may be aggravated by alcohol, anesthetics or sedatives. Rare: cardiac arrhythmias.
CNS: Occasional: dizziness, slow mentation and decreased reaction time.
Pregnancy & Lactation
Lactation: Chlorthalidone appears in breast milk, attaining concentrations of approximately 4% of maternal blood levels. Therefore use in nursing mothers should be avoided.
Precautions & Warnings
Liver disease: There is a risk of precipitating hepatic encephalopathy in patients with liver cirrhosis and ascites.
Use in pregnancy: It is better to avoid Chlorthalidone as it crosses the placenta.
Use in Lactation: In lactating mother, significant amount of Chlorthalidone enter breast milk; like other long-acting thiazides, it can suppress lactation. Chlorthalidone should not be prescribed for lactating mother.
Overdose Effects
Storage Conditions
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.